Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nanomedicine ; 8(5): 618-26, 2012 Jul.
Article in English | MEDLINE | ID: mdl-21924224

ABSTRACT

To enhance the bioavailability of the poorly water-soluble drug talinolol, a self-nanoemulsifying drug delivery system (SNEDDS) comprising 5% (w/v) Brij-721 ethanolic solution (Smix), triacetin, and water, in the ratio of 40:20:40 (% w/w) was developed by constructing pseudo-ternary phase diagrams and evaluated for droplet size, polydispersity index, and surface morphology of nanoemulsions. The effect of nanodrug carriers on drug release and permeability was assessed using stripped porcine jejunum and everted rat gut sac method and compared with hydroalcoholic drug solution, oily solution, and conventional emulsion and suspension. The SNEDDS showed a significant (P < 0.001) increase in drug release, permeability, and in vivo bioavailability as compared to drug suspension. This may be attributed to increased solubility and enhanced permeability of the drug from nanosized emulsion. FROM THE CLINICAL EDITOR: In this study, a self-nanoemulsifying drug delivery system was utilized to enhance the bioavailability of the poorly water-soluble beta-blocker talinolol. Significant increase in drug release, permeability, and in vivo bioavailability were demonstrated as compared to standard drug suspension.


Subject(s)
Biological Availability , Drug Delivery Systems/methods , Emulsions , Nanoparticles/chemistry , Adrenergic beta-1 Receptor Antagonists/chemistry , Adrenergic beta-1 Receptor Antagonists/pharmacology , Animals , Drug Carriers/chemistry , Drug Carriers/pharmacology , Emulsions/chemistry , Emulsions/pharmacology , Intestines/drug effects , Male , Organ Culture Techniques , Permeability/drug effects , Propanolamines/chemistry , Propanolamines/pharmacology , Rats , Rats, Wistar , Solubility , Surface Properties/drug effects , Swine
2.
J Chromatogr Sci ; 49(10): 786-95, 2011.
Article in English | MEDLINE | ID: mdl-22080807

ABSTRACT

A reversed-phase high-performance liquid chromatographic method is developed and validated for the quantitative determination of talinolol and to characterize its degradation products. A very good resolution between peaks is achieved using a C18 column at 40°C. The mobile phase comprises of a mixture of acetonitrile and potassium dihydrogen orthophosphate buffer (pH 4.4) in the ratio of 27:73 (v/v). The method is validated with respect to linearity, accuracy, precision, robustness, and forced degradation studies, which further proved the stability indicating power. During the forced degradation studies, talinolol is observed to be labile to hydrolytic stress and thermal stress (in the solution form). However, it is stable to the oxidative, photolytic, and thermal stress (in the solid form). The degraded products formed are investigated by electrospray ionization (ESI), time-of-flight mass spectrometry, nuclear magnetic resonance, and infrared spectroscopy. A possible degradation pathway is outlined based on the results. The method is found to be sensitive with a detection limit of 0.125 µg/mL and a quantitation limit of 0.378 µg/mL. The method is also demonstrated to be robust, as it is resistant to small variations of chromatographic variables such as pH, mobile phase composition, flow rate, and column temperature.


Subject(s)
Chromatography, High Pressure Liquid/methods , Chromatography, Reverse-Phase/methods , Propanolamines/chemistry , Dosage Forms , Drug Stability , Hydrogen-Ion Concentration , Linear Models , Oxidation-Reduction , Photolysis , Propanolamines/analysis , Reproducibility of Results , Sensitivity and Specificity , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...